Phase II, single-center, double-blind, randomized, placebo-controlled clinical trial to explore the efficacy and safety of IV melatonin in patients with Covid-19 admitted to the ICU (melcovid study).
COMMERCIAL CLINICAL TRIAL
Clinical trial information
- Promoter: PhRMAMEL SL
- Phase: II
- Execution start: 15/08/2020
- End of execution: 06/02/2021
- IP: DARIO ACUÑA CASTROVIEJO